Picture of SHL Telemedicine logo

SHLTN SHL Telemedicine Income Statement

0.000.00%
ch flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Annual income statement for SHL Telemedicine, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue48.941.940.249.659
Cost of Revenue
Gross Profit30.223.520.624.627.2
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses36.936.839.850.164.2
Operating Profit125.080.396-0.497-5.17
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes11.54.770.077-13.51.31
Provision for Income Taxes
Net Income After Taxes10.15.70.278-13.90.215
Minority Interest
Net Income Before Extraordinary Items
Net Income10.15.70.278-14.1-0.076
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income10.15.70.278-14.1-0.076
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.9440.5650.029-0.972-0.005
Dividends per Share